pneumonia
lead
caus
death
unit
state
worldwid
center
diseas
control
death
mortal
world
health
organ
multipl
respiratori
virus
bacteria
caus
infect
lead
sever
pneumonia
recogn
high
proport
communityacquir
pneumonia
caus
coinfect
pathogen
includ
influenza
virus
parainfluenza
virus
respiratori
syncyti
viru
rsv
human
metapneumoviru
hmpv
pneumococcu
group
streptococcu
pyogen
ga
other
alon
variou
combin
caus
million
ambulatori
care
visit
pneumonia
thousand
death
year
unit
state
result
econom
burden
greater
billion
dollar
file
marri
addit
otiti
media
lead
reason
visit
pediatrician
million
visit
per
year
center
diseas
control
death
mortal
center
diseas
control
estim
burden
acut
otit
externa
increas
health
care
cost
pathogen
although
otiti
media
classic
consid
bacteri
diseas
increas
amount
evid
suggest
viral
infect
common
caus
great
deal
acut
otiti
media
aom
result
coinfect
two
pathogen
heikkinen
multipl
virus
bacteria
particip
coinfect
lung
middl
ear
one
import
influenza
viru
although
influenza
major
public
health
threat
bacteri
coinfect
complic
influenza
contribut
greatli
exacerb
diseas
sever
detail
descript
fatal
case
date
far
back
eighteenth
centuri
laennec
indic
viralbacteri
coinfect
recogn
preval
hundr
year
sinc
studi
taken
place
infam
event
spanish
flu
pandem
million
death
complic
bacteri
coinfect
moren
et
al
although
signific
improv
regard
health
care
made
new
pathogen
strain
emerg
complic
bacteri
coinfect
continu
approxim
sever
fatal
case
pandem
nearli
onethird
pandem
bacteri
complic
louria
et
al
weinberg
et
al
furthermor
bacteri
coinfect
identifi
mortal
high
despit
appropri
antibiot
use
major
case
kumar
jain
et
al
palacio
et
al
today
well
recogn
bacteri
pneumonia
complic
diseas
initi
respiratori
pathogen
like
influenza
virus
pneumococcu
remain
frequent
identifi
bacteri
pathogen
associ
influenza
infect
common
caus
communityacquir
pneumonia
cap
despit
use
pneumococc
conjug
vaccin
pcv
children
adult
nelson
et
al
howev
last
decad
aureu
domin
influenzaassoci
childhood
fatal
us
account
death
bacteri
coinfect
aureu
like
becom
common
caus
fulmin
coinfect
due
emerg
countri
methicillinresist
clonotyp
mrsa
unclear
strain
like
lead
secondari
pneumonia
influenza
circul
strain
current
vaccin
aureu
group
streptococcu
occasion
complic
viral
infect
chausse
et
al
present
fall
behind
pneumococcu
aureu
preval
littl
systemat
surveil
bacteri
coinfect
season
influenza
continu
threat
public
health
led
increas
research
copathogenesi
pneumonia
due
influenza
virus
bacteri
pathogen
review
short
et
al
bosch
et
al
metzger
sun
mcculler
research
significantli
improv
current
state
knowledg
influenza
coinfect
use
anim
model
recent
use
theoret
model
key
question
regard
transmiss
invas
pathogen
remain
unansw
identifi
bacteri
coinfect
render
mild
influenza
infect
fatal
key
effect
combat
pneumonia
prepar
futur
influenza
pandem
influenza
pandem
arm
forc
sever
countri
made
detail
account
infecti
diseaserel
ill
sinc
effort
world
war
sever
impact
brundag
shank
shank
et
al
led
first
anim
studi
confirm
bacteria
contribut
diseas
influenza
viru
infect
use
filter
unfilt
human
sputum
wherri
butterfield
experi
follow
shope
conduct
control
experi
pig
swine
influenza
viru
sui
shope
franci
torregrosa
use
mous
model
mouseadapt
influenza
apuerto
viru
togeth
pneumococcu
aureu
h
influenza
franci
de
torregrosa
sinc
varieti
anim
model
use
studi
coinfect
fig
sequenti
viralbacteri
mous
model
pneumonia
character
detail
remain
use
welldefin
system
investig
coinfect
particularli
given
lack
comprehens
data
natur
infect
human
initi
model
subleth
dose
type
laboratori
strain
pneumococcu
reproduc
caus
sever
secondari
bacteri
pneumonia
given
intranas
balbc
mice
mcculler
rehg
influenza
viru
infect
preced
bacteri
challeng
observ
synergist
diseas
interv
day
inocul
organ
result
sever
diseas
peak
sever
occur
pneumococcu
given
day
postvir
infect
simultan
administr
two
pathogen
addit
effect
morbid
rather
synergist
effect
observ
sequenti
infect
model
later
improv
engin
pneumococc
strain
express
luciferas
allow
quantit
bioluminesc
imag
track
progress
infect
live
mice
mcculler
bartmess
multipl
strain
influenza
includ
pandem
viru
prime
mice
secondari
pneumonia
wanzeck
et
al
dose
necessari
compar
result
differ
straindepend
fashion
addit
virus
eg
rhinoviru
adenoviru
coronaviru
parainfluenza
viru
hmpv
rsv
use
within
model
framework
review
bosch
et
al
varieti
clinic
outcom
model
differ
pneumococc
strain
includ
pneumonia
without
bacteremia
sepsi
secondari
seed
organ
lead
pneumonia
otiti
media
sinus
peltola
et
al
mcculler
et
al
smith
et
al
furthermor
multipl
bacteri
speci
synerg
influenza
virus
caus
diseas
fig
mous
model
influenzabacteri
coinfect
sever
limit
exampl
virus
replic
well
mice
requir
produc
robust
reproduc
effect
limit
affect
certainti
conclus
extrapol
human
mitig
somewhat
use
differ
speci
mice
includ
strain
behav
similarli
balbc
strain
karlstrom
et
al
strain
highli
permiss
varieti
human
influenza
strain
alymova
et
al
addit
ferret
model
use
confirm
result
found
use
mous
model
answer
question
strainrel
differ
pathogenesi
sinc
ferret
suscept
human
virus
exhibit
diseas
cours
similar
human
peltola
et
al
mcculler
et
al
chinchilla
weanl
ferret
also
infect
varieti
pneumococc
strain
hajek
et
al
mcculler
et
al
although
diseas
manifest
map
precis
mous
model
limit
data
virus
bacteria
ferret
model
unpublish
experi
laboratori
shown
aureu
caus
respiratori
infect
ferret
even
anim
preinfect
influenza
anoth
limit
mous
model
poor
transmiss
potenti
respiratori
virus
bacteria
mice
thu
requir
use
altern
model
neonat
mice
diavatopoulo
et
al
ferret
mcculler
et
al
transmiss
studi
earli
anim
model
aom
util
chinchilla
due
larg
access
middl
ear
space
hajek
et
al
studi
demonstr
greatest
incid
aom
occur
anim
receiv
bacteria
day
follow
influenza
hajek
et
al
similar
data
concern
time
pneumonia
recent
juvenil
infant
mous
model
develop
diseas
young
adult
children
respect
mimick
mcculler
et
al
diavatopoulo
et
al
similar
model
use
investig
effect
influenza
virus
bacteri
colon
tong
et
al
nakamura
et
al
studi
viralbacteri
interact
anim
model
significantli
increas
knowledg
transmiss
pathogen
coinfect
howev
age
gender
weight
exposur
anesthesia
contribut
suscept
infect
anim
model
extrem
care
must
taken
pathogenesi
studi
control
variabl
addit
studi
must
care
select
pathogen
strain
inoculum
size
sequenc
time
infect
sinc
influenc
progress
bacteri
pneumonia
follow
influenza
influenza
virus
readili
transmit
person
person
via
small
larg
respiratori
droplet
sneez
cough
success
transmiss
infect
typic
begin
day
prior
develop
symptom
last
day
adult
day
children
world
health
organ
write
group
et
al
influenza
virus
spread
larg
droplet
six
feet
away
pneumococc
transmiss
thought
requir
close
contact
individu
recent
evid
howev
suggest
distanc
lengthen
individu
viru
infect
fact
epidemiolog
studi
found
connect
upper
respiratori
tract
urt
infect
like
viral
origin
increas
bacteri
transmiss
carriag
preval
gwaltney
et
al
fresnadillo
pettigrew
et
al
murphi
et
al
ansaldi
et
al
influenza
viru
impact
pneumococc
transmiss
recent
illustr
ferret
model
transmiss
event
recipi
acquisit
increas
distanc
necessari
success
bacteri
acquisit
decreas
mcculler
et
al
bacteri
titer
diseas
sever
intensifi
contact
ferret
relationship
examin
infant
mous
model
influenza
viru
replic
nasopharyng
bacteri
growth
deem
essenti
pneumococc
transmiss
litterm
diavatopoulo
et
al
short
et
al
outcom
may
seen
influenzapneumococc
pair
sinc
observ
effect
viral
bacteri
strain
depend
instanc
influenza
virus
enhanc
pneumococc
sinus
aom
induc
bacteri
colon
diseas
frequent
influenza
b
virus
peltola
et
al
short
et
al
similarli
colon
aom
develop
greater
pneumococc
serotyp
compar
serotyp
mcculler
et
al
although
precis
mechan
respons
enhanc
transmiss
profil
influenza
virus
provid
pneumococci
current
unknown
like
due
increas
pathogen
densiti
frequenc
secret
event
eg
sneez
cough
infect
individu
combin
decreas
immun
resist
natur
barrier
break
person
newli
expos
variou
bacteri
speci
frequent
colon
nasopharynx
reach
balanc
mucos
immun
respons
harm
host
state
bacteria
exist
either
biofilm
move
intracellular
extracellular
state
often
colon
strain
remain
upper
airway
sinc
movement
lower
respiratori
tract
inhibit
physic
barrier
eg
mucociliari
mechan
immun
respons
eg
resid
immun
cell
complement
mucos
antibodi
manner
breakdown
physic
barrier
disrupt
host
respons
result
bacteria
emerg
biofilm
mark
et
al
invas
infect
pneumonia
occur
within
short
period
time
new
strain
acquir
environ
rather
longterm
carriag
isol
dissemin
site
bodi
like
due
colon
strain
limit
system
immun
pathogenspecif
serum
igg
prevent
success
invas
lower
airway
may
toler
carriag
review
mcculler
et
al
mous
model
bacteria
deliv
directli
lung
mimic
directinhal
scenario
unclear
whether
scenario
physiolog
relev
human
whether
period
colon
nasopharynx
must
occur
prior
invas
dissemin
review
mcculler
inoculum
size
volum
length
anesthesia
influenc
much
bacteria
reach
lower
airway
thu
diseas
model
studi
ferret
mous
aom
model
hand
use
colon
prerequisit
pneumonia
aom
natur
infect
site
instig
influenza
virus
liveattenu
influenza
vaccin
laiv
result
prolong
bacteri
colon
enhanc
bacteri
replic
within
nasopharynx
mice
ferret
peltola
et
al
nakamura
et
al
short
et
al
mina
et
al
may
mediat
type
interferon
respons
bacteri
toxin
pneumococc
pneumolysin
nakamura
et
al
nasopharyng
colon
result
bacteri
migrat
middl
ear
via
eustachian
tube
mice
aom
model
anim
becom
colon
pneumococcu
within
h
inocul
experi
recurr
episod
viru
infect
mcculler
et
al
develop
aom
resolut
occur
within
h
colon
persist
nearli
day
mcculler
et
al
chinchilla
model
anim
infect
influenza
viru
experi
neg
middl
ear
pressur
eardrum
inflamm
associ
epitheli
damag
cellular
mucos
debri
accumul
eustachian
tube
giebink
et
al
similarli
virusmedi
inflamm
hear
loss
observ
neonat
mice
ferret
rarey
et
al
short
et
al
howev
contrast
find
chinchilla
minim
eustachian
tube
damag
observ
bacteri
local
specif
suggest
invas
techniqu
observ
model
unlik
relev
bacteri
aom
short
et
al
nevertheless
increas
patholog
may
support
bacteri
replic
middl
ear
bacteria
success
migrat
lung
combin
increas
bacteri
burden
accompani
intens
inflammatori
respons
may
result
host
develop
pneumonia
earli
stage
pneumonia
mark
capillari
congest
fluid
alveolar
region
provid
medium
pneumococci
readili
grow
review
mcculler
blood
vessel
becom
permeabl
inflammatori
cell
allow
enter
lung
receptor
becom
upregul
bacteria
easili
adher
invad
kill
epitheli
cell
combin
effect
result
signific
inflamm
hallmark
pneumonia
coinfect
host
rel
state
immun
dysregul
heighten
inflammatori
antiinflammatori
respons
review
short
et
al
bosch
et
al
metzger
sun
mcculler
like
due
express
variou
pathogen
factor
bacteri
cytotoxin
like
pneumococc
pneumolysin
tuomanen
et
al
kadioglu
et
al
aureu
pantonvalentin
leukocidin
pvl
niemann
et
al
b
pertussi
toxin
pt
ayala
et
al
known
influenc
host
inflamm
may
work
concert
viral
cytotoxin
bacteri
factor
may
intensifi
cell
death
inflammatori
signal
result
pore
form
influenza
cytotox
protein
chen
et
al
protein
influenza
virus
increas
patholog
effect
caus
cell
death
increas
viral
replic
alter
inflammatori
respons
primari
viral
infect
bacteri
coinfect
conenello
et
al
mcauley
et
al
b
smith
et
al
act
proapoptot
fashion
due
mitochondri
target
sequenc
abil
form
pore
interact
membranebas
protein
chen
et
al
gibb
et
al
chanturiya
et
al
zamarin
et
al
danishuddin
et
al
mcauley
et
al
like
result
death
epitheli
cell
immun
cell
may
balanc
high
replic
abil
support
rapid
spread
cell
monolay
therebi
contribut
virul
vivo
zamarin
et
al
mcauley
et
al
b
smith
et
al
varga
et
al
kinet
analys
suggest
mechan
impact
viral
load
later
stage
influenza
infect
overshadow
promin
mechan
secondari
bacteri
infect
smith
et
al
cellular
effect
map
specif
set
amino
acid
ctermin
end
protein
found
earli
twentieth
centuri
strain
mcauley
et
al
although
rare
hai
et
al
serin
posit
ie
polymorph
impact
virul
highli
pathogen
strain
fulllength
eg
less
pathogen
strain
truncat
eg
conenello
et
al
hai
et
al
varga
et
al
polymorph
facilit
bind
mitochondri
antiviralsign
mav
protein
adaptor
protein
subsequ
inhibit
interferon
product
varga
et
al
result
viral
virul
primari
infect
secondari
bacteri
infect
model
sever
exacerb
relev
mechan
may
abil
modul
immun
respons
influenza
infect
coinfect
high
proinflammatori
activ
intensifi
diseas
anim
model
particularli
respect
induct
sever
bacteri
coinfect
mcauley
et
al
alymova
et
al
weeksgorosp
et
al
mark
larg
influx
immun
cell
cytokin
storm
conenello
et
al
mcauley
et
al
pathogen
pandem
strain
elev
neutrophil
macrophag
contribut
patholog
tissu
destruct
observ
bacteri
coinfect
mcauley
et
al
like
due
regul
type
interferon
respons
le
goffic
et
al
conenello
et
al
varga
et
al
apoptot
monocyt
infect
influenza
chen
et
al
gibb
et
al
zamarin
et
al
specif
molecular
signatur
facilit
inflammatori
environ
identifi
mcauley
et
al
amino
acid
ctermin
portion
select
strain
posit
associ
inflamm
hypercytokinemia
infect
anim
neg
correl
surviv
precis
mechan
contribut
signatur
singli
combin
unclear
pathogen
pandem
strain
like
impact
possess
four
inflammatori
signatur
togeth
polymorph
pandem
strain
also
four
amino
acid
lack
polymorph
subsequ
circul
strain
becam
truncat
lineag
around
mcauley
et
al
mutat
lineag
result
loss
inflammatori
signatur
fact
antibacteri
phenotyp
emerg
lineag
virus
invad
bacteria
compet
via
express
rather
synerg
alymova
et
al
weeksgorosp
et
al
express
signatur
length
protein
vari
wide
within
influenza
virus
gener
virus
signatur
full
set
polymorph
strongli
support
bacteri
pathogen
truncat
result
intermedi
phenotyp
zell
et
al
singl
substitut
posit
confer
antiinflammatori
properti
weeksgorosp
et
al
rang
phenotyp
highlight
intric
complic
natur
influenza
infect
coinfect
link
specif
molecular
signatur
pathogen
import
note
effect
demonstr
anim
model
use
specif
virus
eg
alymova
et
al
swine
weeksgorosp
et
al
virus
particular
interest
studi
sinc
littl
divers
typic
full
length
like
possess
full
inflammatori
panel
except
polymorph
smith
mcculler
sinc
phagocyt
cell
critic
creat
bactericid
environ
surpris
cell
impact
viral
bacteri
mechan
secondari
infect
occur
activ
neutrophil
macrophag
dampen
along
cytokin
product
natur
killer
nk
cell
becom
impair
influenza
viru
infect
undergo
addit
suppress
coinfect
result
heighten
express
small
et
al
function
suppress
cell
occur
type
interferon
place
epitheli
cell
antivir
state
alter
chemotact
function
joyc
et
al
shahangian
et
al
le
goffic
et
al
conenello
et
al
nakamura
et
al
tian
et
al
li
et
al
instanc
neutrophil
chemoattract
kc
shahangian
et
al
macrophag
chemoattract
nakamura
et
al
becom
downregul
inhibit
recruit
immun
cell
lead
ineffici
bacteri
clearanc
may
also
decreas
cytokin
aureu
coinfect
increas
inflamm
decreas
viral
bacteri
clearanc
kudva
et
al
product
increas
influenza
resolut
downregul
bacteri
scaveng
receptor
eg
marco
macrophag
leav
phagocyt
cell
suppress
cytokin
profil
alter
didierlaur
et
al
sun
metzger
addit
proinflammatori
eg
seki
et
al
smith
et
al
shahangian
et
al
nakamura
et
al
mchugh
et
al
antiinflammatori
cytokin
eg
van
der
sluij
et
al
becom
inflat
compound
downstream
event
like
macrophag
neutrophil
recruit
dendrit
cell
function
influenzapneumococc
coinfect
sun
metzger
shahangian
et
al
wu
et
al
nakamura
et
al
kuri
et
al
even
viral
bacteri
pathogen
induc
apoptosi
phagocyt
cell
colamussi
et
al
engelich
et
al
kobayashi
et
al
mcname
harmsen
thu
leav
infect
area
sever
damag
mani
respons
requir
time
activ
thu
suscept
host
bacteri
pathogen
follow
influenza
viru
infect
indic
effect
may
fulli
realiz
viral
preinfect
inde
novel
analys
coinfect
kinet
identifi
detail
domin
mechan
drive
influenzapneumococc
synergi
direct
viraldepend
reduct
bacteri
phagocytosi
alveolar
macrophag
smith
et
al
predict
phagocytosi
reduc
day
influenza
viru
infect
later
confirm
major
driver
influenzapneumococc
synergi
mous
model
label
track
cell
influenza
infect
ghoneim
et
al
experi
show
resid
macrophag
popul
declin
influenza
progress
suggest
influenza
viru
directli
deplet
cell
rather
simpli
reduc
function
furthermor
bacteri
outgrowth
correl
level
deplet
offer
new
insight
time
bacteri
infect
profound
impact
diseas
outcom
ghoneim
et
al
vigor
antivir
inflammatori
respons
begin
subsid
new
state
innat
immun
activ
may
alter
respons
new
pathogen
insult
reach
lung
becom
repopul
resid
alveolar
macrophag
recruit
macrophag
prolifer
differenti
attempt
return
lung
homeostasi
woundheal
process
coordin
antiinflammatori
respons
character
van
der
sluij
et
al
hussel
cavanagh
suppress
pathogen
recognit
system
review
metzger
sun
recoveri
phase
host
becom
immunolog
desensit
local
system
van
der
sluij
et
al
didierlaur
et
al
last
sever
week
prolong
opportun
bacteri
invas
degre
length
suppress
viral
straindepend
ludewick
et
al
occur
divers
mechan
instanc
alveolar
macrophag
high
express
homeostat
moieti
regulatori
antiinflammatori
ligand
barclay
et
al
mina
liversidg
snelgrov
et
al
jiangshieh
et
al
becom
desensit
express
apoptot
immun
cell
increas
open
airway
bacteri
invas
gould
et
al
conjunct
absenc
mice
inhibit
bacteri
outgrowth
prevent
migrat
bacteria
exogen
site
blood
influenzainfect
mice
gould
et
al
elev
glucocorticoid
level
also
caus
sustain
immunosuppress
demonstr
model
listeria
monocytogen
coinfect
jamieson
et
al
inflammatori
natur
influenzapneumococc
coinfect
extend
middl
ear
invas
middl
ear
inflamm
regardless
pathogen
origin
suffici
induc
aom
influenza
virus
initi
inflamm
abramson
et
al
short
et
al
caus
hear
loss
instig
bacteri
growth
within
ear
caviti
viral
straindepend
cell
tropism
independ
manner
short
et
al
inflamm
aom
character
influx
neutrophil
express
key
proinflammatori
gene
ie
abramson
et
al
short
et
al
chinchilla
studi
indic
immunosuppress
rather
inflamm
key
mechan
contribut
enhanc
pneumococc
replic
sinc
influenza
virus
inhibit
neutrophil
render
clearanc
ineffect
abramson
et
al
howev
also
hypothes
enhanc
bacteri
growth
result
nutrient
becom
avail
area
damag
respons
short
et
al
experi
clearli
necessari
elucid
underli
relationship
viral
replic
inflamm
aom
mechan
discuss
thu
far
detail
viru
affect
host
respons
invad
bacteria
relationship
somewhat
complementari
howev
sinc
rebound
viral
load
reduc
viral
clearanc
consist
observ
anim
model
mcculler
rehg
iverson
et
al
weeksgorosp
et
al
smith
et
al
rapid
viral
repli
suggest
fastact
mechan
may
occur
direct
interact
two
pathogen
bacteri
interfer
antivir
immun
virul
factor
synerg
smith
et
al
kinet
studi
suggest
pneumococci
directli
interact
influenzainfect
epitheli
cell
caus
sudden
releas
viru
smith
et
al
experiment
studi
craft
confirm
predict
precis
effect
bacteri
virul
factor
like
type
specif
aureu
may
capabl
cleav
influenza
hemaggluttinin
enhanc
invas
host
cell
thu
impact
viral
load
tashiro
et
al
feasibl
addit
although
unknown
bacteri
virul
factor
immunemodulatori
effect
could
interfer
viral
clearanc
tcellmedi
infect
cell
clearanc
innat
immun
compon
determin
bacteri
gene
product
variou
speci
similar
effect
infect
complement
viral
factor
import
larg
unexplor
area
anoth
interest
area
investig
anim
model
idea
respiratori
gastrointestin
microbiom
affect
develop
antivir
respons
pathogen
ichinoh
et
al
licciardi
et
al
abt
et
al
wang
et
al
understand
commens
speci
influenc
host
immun
statu
may
help
explain
heterogen
respons
pathogen
invas
sever
antivir
drug
target
variou
influenza
viru
compon
current
develop
review
hayden
neuraminidas
inhibitor
nai
one
class
drug
becom
pillar
influenza
treatment
recent
year
nai
act
block
viru
bud
infect
cell
therebi
prevent
spread
viru
neighbor
cell
moscona
nai
therapi
prevent
secondari
bacteri
pneumonia
anim
infect
influenza
mice
given
nai
treatment
within
h
postinfluenza
infect
prophylact
experienc
improv
surviv
due
delay
develop
progress
pneumonia
nai
treatment
decreas
viral
load
reduc
secondari
bacteri
infect
treatment
later
stage
influenza
viru
infect
ie
day
reduc
bacteri
invas
without
impact
viral
load
signifi
mechan
independ
replic
inhibit
play
mcculler
action
may
directli
indirectli
lessen
effect
viral
virul
factor
prevent
receptor
exposur
reduc
use
sialic
acid
catabol
substrat
andor
activ
immunolog
compon
viral
straindepend
manner
review
mcculler
although
nai
resist
remain
problemat
may
reduc
combin
therapi
treatment
multipl
nai
inhibit
antivir
efficaci
duval
et
al
nai
combin
antibiot
hand
facilit
recoveri
influenza
alter
coinfect
pathogenesi
infect
anim
mcculler
antivir
eg
peramivir
laninamivir
nai
favipiravir
rna
polymeras
inhibitor
yet
licens
may
provid
benefit
coinfect
host
yet
test
anim
coinfect
model
import
note
nai
specif
target
influenza
viru
na
inhibit
bacteri
na
clinic
relev
dose
nishikawa
et
al
nai
may
reduc
incid
bacteri
pneumonia
thu
antibiot
requir
na
deriv
invas
commens
bacteria
may
antagon
effect
nishikawa
et
al
thu
nai
therapi
could
differenti
bacterialdepend
effect
well
unlik
antivir
interrupt
diseas
progress
prevent
viral
spread
antibiot
work
elimin
pathogen
directli
antibiot
howev
kill
bacteria
mechan
harm
repercuss
instanc
therapi
cell
wall
activ
agent
eg
ampicillin
mainstay
treatment
communityacquir
pneumonia
children
bradley
et
al
caus
signific
inflamm
lung
injuri
anim
model
et
al
characterist
inflamm
secondari
bacteri
infect
due
immun
cell
respond
releas
bacteri
compon
cell
wall
compon
lysi
karlstrom
et
al
thu
altern
treatment
elimin
pathogen
preserv
host
integr
desir
antibiot
reduc
neutrophil
influx
cytokin
thu
circumv
inflammatori
tissu
damag
benefici
coinfect
anim
karlstrom
et
al
liu
et
al
particular
protein
synthesi
inhibitor
eg
clindamycin
macrolid
eg
azithromycin
antiinflammatori
properti
addit
bactericid
activ
therebi
clinic
cure
mice
influenzaassoci
pneumococc
pneumonia
et
al
nevertheless
antibiot
treatment
alon
suboptim
antiinflammatori
agent
corticosteroid
eg
dexamethason
conjunct
antibiot
therapi
improv
betalactaminduc
immunopatholog
mortal
anim
sever
pneumonia
howev
give
dexamethason
prophylact
influenza
infect
neg
impact
adapt
immun
result
reduc
viral
clearanc
ghoneim
mcculler
thu
use
immunemodulatori
approach
may
best
reserv
sever
infect
inflamm
drive
poor
outcom
avoid
primari
viral
infect
detriment
effect
host
respons
may
result
given
benefit
antiinflammatori
treatment
import
inflamm
viralbacteri
coinfect
better
success
may
occur
specif
inflammatori
pathway
pathogen
factor
target
review
mcculler
vaccin
remain
fundament
prevent
influenza
bacteri
infect
data
anim
model
indic
vaccin
influenza
virus
effect
circumv
bacteri
associ
pneumonia
huber
et
al
chausse
et
al
mina
et
al
may
support
colon
replic
urt
mina
et
al
import
caveat
current
vaccin
influenza
virus
partial
protect
relat
strain
may
suffici
allevi
bacteri
complic
hand
antibacteri
vaccin
import
block
specif
bacteria
target
prevent
clinic
sever
influenza
infect
reduc
coinfect
compon
vaccin
anim
bacteria
eg
pneumococcu
h
influenza
prevent
invas
diseas
caus
pathogen
protect
limit
vaccinespecif
type
efficaci
may
lost
influenza
viru
infect
anim
mina
et
al
addit
vaccin
coinfect
bacteria
aureu
current
avail
interestingli
vaccin
liveattenu
b
pertussi
vaccin
protect
lethal
challeng
influenza
viru
control
cytokin
respons
lead
virusmedi
inflamm
li
et
al
although
vaccin
yet
approv
use
human
promis
may
benefit
prophylact
agent
infect
influenza
virus
grow
bodi
work
model
vivo
influenza
viru
infect
improv
knowledg
viral
life
cycl
viral
control
host
pathogen
differ
strain
efficaci
antivir
treatment
review
smith
ribeiro
beauchemin
handel
smith
perelson
model
character
spread
viru
earli
infect
yield
estim
strainspecif
viral
infect
product
rate
infect
cell
life
span
infecti
viru
halflif
amen
experiment
investig
studi
model
data
human
larg
anim
nasal
wash
titer
avail
thu
restrict
studi
nasopharyng
infect
baccam
et
al
saenz
et
al
canini
carrat
pawelek
et
al
model
howev
take
advantag
data
collect
mous
model
includ
pathogen
immunolog
measur
studi
invas
lung
infect
handel
et
al
miao
et
al
smith
et
al
viral
load
dynam
accur
model
use
targetcel
limit
fig
undefin
mechan
primari
mean
viral
control
exclud
specif
immun
respons
baccam
et
al
smith
et
al
import
note
model
discount
fact
immunolog
factor
may
drive
influenza
viru
pathogenesi
inform
simpli
extract
viral
load
smith
et
al
miao
et
al
quantifi
effect
host
factor
viral
replic
restrict
limit
amount
data
detail
innat
immun
respons
review
smith
perelson
data
aris
new
quantit
descript
influenza
viru
kinet
develop
undoubtedli
aid
experiment
interpret
kinet
model
depict
bacteri
infect
excit
new
tool
use
studi
pathogenesi
smith
et
al
capit
data
obtain
mous
model
system
character
dosedepend
innat
immun
control
pneumococc
invas
quantifi
contribut
alveolar
macrophag
neutrophil
inflammatori
macrophag
cytokin
damag
bacteri
pathogenesi
smith
et
al
model
analysi
reveal
exact
threshold
bacteri
establish
growth
erad
alveolar
macrophag
play
central
role
dosedepend
invas
abil
pneumococci
sole
depend
number
phagocyt
abil
resid
macrophag
initi
present
thu
alter
resid
cell
death
anteced
viral
infect
would
result
immedi
pathogen
invas
rapid
neutrophil
influx
could
facilit
bacteri
remov
pneumococcalinduc
neutrophil
apoptosi
hinder
complet
erad
process
also
depend
alveolar
macrophag
whether
engag
damag
control
rather
bacteri
clearanc
inflammatori
macrophag
littl
effect
clearanc
still
contribut
respiratori
tract
damag
model
success
captur
biochem
cellular
immunolog
interact
pneumococci
host
identifi
critic
process
drive
pathogenesi
model
interact
two
pathogen
requir
combin
previous
develop
singl
infect
model
thu
far
model
depict
coinfect
one
formul
influenzapneumococc
coinfect
use
model
discuss
fig
smith
et
al
quantit
enhanc
bacteri
growth
viral
rebound
evalu
prior
hypothes
interact
influenza
pneumococcu
host
care
model
develop
analys
show
enhanc
bacteri
adher
epitheli
cell
respect
invas
cell
death
neglig
compar
viralinduc
impair
alveolar
macrophag
mechan
predict
avail
initi
model
effort
pinpoint
process
drive
influenzapneumococc
synergi
subject
examin
laboratori
smith
et
al
fact
decreas
phagocytosi
alveolar
macrophag
later
determin
result
influenza
viru
directli
kill
cell
ghoneim
et
al
remark
model
smith
et
al
experi
ghoneim
et
al
agre
cell
diminish
baselin
level
within
day
receptormedi
mechan
may
still
drive
synergi
although
context
enhanc
invas
model
predict
bacteri
interact
virusinfect
epitheli
cell
releas
viru
thu
increas
viral
load
postbacteri
invas
bacteri
proteas
na
may
liber
viru
manner
viral
na
aureu
proteas
activ
influenza
viru
ha
cleavag
enhanc
viral
invas
host
cell
tashiro
et
al
furthermor
commens
bacteria
eg
miti
nonaka
et
al
beighton
whiley
certain
pneumonia
scanlon
et
al
actinomyc
naeslundii
viscosu
moncla
braham
porphyromona
gingivali
moncla
et
al
orali
homer
et
al
secret
na
exogen
na
rescu
influenza
viru
replic
viral
na
miss
inhibit
liu
air
hugh
et
al
nishikawa
et
al
thu
feasibl
na
possess
bacteri
speci
act
manner
predict
model
uncov
underli
mechan
combin
vitro
vivo
experi
virus
bacteria
exhibit
differenti
express
na
necessari
smith
et
al
becom
better
appreci
pneumonia
frequent
caus
coinfect
pathogen
viralmedi
mechan
also
import
invas
infect
otiti
media
underli
relationship
viral
bacteri
densiti
inflamm
host
microbiom
influenza
coinfect
except
complex
even
grow
bodi
work
detail
variou
aspect
viralbacteri
coinfect
determin
precis
contribut
interrel
factor
challeng
furthermor
studi
coinfect
becom
problemat
due
numer
site
pathogen
time
hostspecif
variat
consid
thu
necessari
employ
next
gener
analys
use
mixtur
anim
model
kinet
model
goal
obtain
result
translat
infect
human
import
area
consider
includ
determin
differ
bacteri
virul
factor
leverag
environ
set
forth
influenza
virus
caus
diseas
time
sequenti
infect
impact
aforement
mechan
synergist
relationship
facilit
host
genet
factor
differ
nasopharyng
middl
ear
lung
nich
differ
viral
bacteri
speci
understand
coinfect
biolog
increas
new
differ
data
emerg
data
treatment
option
suitabl
clinic
practic
permiss
investig
focu
prepar
next
influenza
pandem
